References
Dietrich ES, Demmler M, Schulgen G, Fekec K, Mast O, Pelz K, Daschner FD: Nosocomial pneumonia: a cost-of-illness analysis. Infection 2002; 30: 61–67 ai}Gastmeier P, Sohr D, Geffers C, Nassauer A, Daschner F, Ruden H: Are nosocomial infection rates in intensive care units useful benchmark parameters? Infection 2000; 28: 346–350.
Ruef C: Prevalence of nosocomial infections—who knows the true rates? Infection 1997; 25: 203–205.
Fox BC, Imrey PB, Voights MB, Norwood S: Infectious disease consultation and microbiologic surveillance for intensive care unit trauma patients: a pilot study. Clin Infect Dis 2001; 33: 1981–1989.
Yinnon AM: Whither infectious diseases consultations? Analysis of 14,005 consultations from a 5-year period. Clin Infect Dis 2001; 33: 1661–1667.
Halm EA, Switzer GE, Mittman BS, Walsh MB, Chang CC, Fine MJ: What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia? J Gen Intern Med 2001; 16: 599–605
Pfaller MA: Molecular approaches to diagnosing and managing infectious diseases: practicality and costs. Emerg Infect Dis 2001; 7: 312–318.
Garattini L, Tediosi F, Di Cintio E, Yin D, Parazzini F: Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy. AIDS Care 2001; 13:733–741.
Keiser P, Nassar N, Kvanli MB, Turner D, Smith JW, Skiest D: Longterm impact of highly active antiretroviral therapy on HIV-related health care costs. J Acquir Immune Defic Syndr 2001; 27: 14–19.
Klepser DG: Pitfalls associated with commonly used methods for pharmacoeconomic analyses. Pharmacotherapy 2002; 22: 35S–38S.
Pollack HA: Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users. Med Decis Making 2001; 21: 357–367.
Accorsi S, Fabiani M, Lukwiya M, Onek PA, Mattei PD, Declich S: The increasing burden of infectious diseases on hospital services at St Mary's Hospital Lacor, Gulu, Uganda. Am J Trop Med Hyg 2001; 64: 154–158.
Rights and permissions
About this article
Cite this article
Ruef, C. Cost of Infectious Diseases. Infection 30, 59–60 (2002). https://doi.org/10.1007/s15010-002-7202-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-002-7202-8